ArticleJMIR cancer2025

Impact of Immune Checkpoint Inhibitors on Second Primary Cancer Risk in Patients With Metastatic Lung Cancer Using Real-World Data From the TriNetX Network: Retrospective Cohort Study.

Pierre Heudel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.